Recro Pharma Inc (REPH)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
62,500
+27.3%
0.40USD 25,000 |
62,500 +27.3% | 0.40 | USD 25,000 | |
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
30,000
+40.7%
0.40USD 12,000 |
30,000 +40.7% | 0.40 | USD 12,000 | |
| 2023-08-28 | 2023-08-28 | B Purchase |
Chief Executive Officer Executive Director |
125,000
+12.8%
0.40USD 50,000 |
125,000 +12.8% | 0.40 | USD 50,000 | |
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
62,500
+26.1%
0.40USD 25,000 |
62,500 +26.1% | 0.40 | USD 25,000 | |
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
22,222
+9.2%
0.46USD 10,111 |
22,222 +9.2% | 0.46 | USD 10,111 | |
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
37,500
+19.7%
0.40USD 15,000 |
37,500 +19.7% | 0.40 | USD 15,000 | |
| 2023-08-28 | 2023-08-28 | B Purchase | Non-Executive Director |
62,500
+25.4%
0.40USD 25,000 |
62,500 +25.4% | 0.40 | USD 25,000 | |
| 2023-08-28 | 2023-08-24 | B Purchase | Large shareholder |
140,000
+1.4%
0.40USD 56,000 |
140,000 +1.4% | 0.40 | USD 56,000 | |
| 2023-08-25 | 2023-08-24 | B Purchase | Non-Executive Director Large shareholder |
6,250,000
+46.6%
0.40USD 2,500,000 |
6,250,000 +46.6% | 0.40 | USD 2,500,000 | |
| 2023-04-27 | 2023-04-27 | S Sale | Large shareholder |
370,000
-4.2%
0.70USD 259,037 |
370,000 -4.2% | 0.70 | USD 259,037 | |
| 2022-11-16 | 2022-11-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
660
+0.1%
1.71USD 1,129 |
660 +0.1% | 1.71 | USD 1,129 | |
| 2022-10-17 | 2022-10-17 | PP Planned purchase |
Chief Executive Officer Executive Director |
625
+0.1%
1.69USD 1,056 |
625 +0.1% | 1.69 | USD 1,056 | |
| 2022-09-16 | 2022-09-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
714
+0.1%
1.41USD 1,007 |
714 +0.1% | 1.41 | USD 1,007 | |
| 2022-08-17 | 2022-08-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
757
+0.1%
1.26USD 954 |
757 +0.1% | 1.26 | USD 954 | |
| 2022-07-18 | 2022-07-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
1,150
+0.2%
0.81USD 931 |
1,150 +0.2% | 0.81 | USD 931 | |
| 2022-06-17 | 2022-06-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
1,562
+0.3%
0.68USD 1,062 |
1,562 +0.3% | 0.68 | USD 1,062 | |
| 2022-05-18 | 2022-05-16 | PP Planned purchase |
Chief Executive Officer Executive Director |
1,086
+0.2%
0.96USD 1,044 |
1,086 +0.2% | 0.96 | USD 1,044 | |
| 2022-04-20 | 2022-04-19 | B Purchase | Large shareholder |
12,100
+0.2%
1.56USD 18,917 |
12,100 +0.2% | 1.56 | USD 18,917 | |
| 2022-04-20 | 2022-04-18 | B Purchase | Large shareholder |
15,000
+0.3%
1.55USD 23,201 |
15,000 +0.3% | 1.55 | USD 23,201 | |
| 2022-04-20 | 2022-04-18 | B Purchase | Large shareholder |
600
+0.0%
1.52USD 910 |
600 +0.0% | 1.52 | USD 910 | |
| 2022-04-20 | 2022-04-18 | PP Planned purchase |
Chief Executive Officer Executive Director |
625
+0.1%
1.63USD 1,019 |
625 +0.1% | 1.63 | USD 1,019 | |
| 2022-03-22 | 2022-03-18 | B Purchase | Non-Executive Director |
1,000
+3.6%
2.15USD 2,145 |
1,000 +3.6% | 2.15 | USD 2,145 | |
| 2022-03-17 | 2022-03-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
512
+0.1%
1.96USD 1,004 |
512 +0.1% | 1.96 | USD 1,004 | |
| 2022-02-17 | 2022-02-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
571
+0.1%
1.77USD 1,011 |
571 +0.1% | 1.77 | USD 1,011 | |
| 2022-01-19 | 2022-01-18 | PP Planned purchase |
Chief Executive Officer Executive Director |
602
+0.4%
1.68USD 1,011 |
602 +0.4% | 1.68 | USD 1,011 | |
| 2021-12-23 | 2021-12-21 | S Sale | Large shareholder |
99,398
-1.9%
1.55USD 154,236 |
99,398 -1.9% | 1.55 | USD 154,236 | |
| 2021-12-20 | 2021-12-16 | S Sale | Large shareholder |
50,000
-1.0%
1.61USD 80,500 |
50,000 -1.0% | 1.61 | USD 80,500 | |
| 2021-12-17 | 2021-12-15 | PP Planned purchase |
Chief Executive Officer Executive Director |
617
+0.4%
1.61USD 993 |
617 +0.4% | 1.61 | USD 993 | |
| 2021-12-15 | 2021-12-15 | S Sale | Large shareholder |
20,000
-0.4%
1.63USD 32,600 |
20,000 -0.4% | 1.63 | USD 32,600 | |
| 2021-12-15 | 2021-12-14 | S Sale | Large shareholder |
10,602
-0.2%
1.57USD 16,683 |
10,602 -0.2% | 1.57 | USD 16,683 | |
| 2021-12-15 | 2021-12-13 | S Sale | Large shareholder |
20,000
-0.4%
1.63USD 32,502 |
20,000 -0.4% | 1.63 | USD 32,502 | |
| 2021-11-19 | 2021-11-17 | B Purchase | Non-Executive Director |
1,000
+3.7%
1.69USD 1,689 |
1,000 +3.7% | 1.69 | USD 1,689 | |
| 2021-11-16 | 2021-11-12 | B Purchase |
Chief Executive Officer Executive Director |
1,725
+1.1%
1.68USD 2,895 |
1,725 +1.1% | 1.68 | USD 2,895 | |
| 2021-11-16 | 2021-11-12 | B Purchase |
Chief Financial Officer Officer |
50
+0.0%
1.62USD 81 |
50 +0.0% | 1.62 | USD 81 | |
| 2021-11-16 | 2021-11-12 | B Purchase |
Chief Financial Officer Officer |
1,162
+0.3%
1.65USD 1,916 |
1,162 +0.3% | 1.65 | USD 1,916 | |
| 2021-06-14 | 2021-06-11 | S Sale | Large shareholder |
266,667
-5.7%
2.20USD 587,521 |
266,667 -5.7% | 2.20 | USD 587,521 | |
| 2021-06-14 | 2021-06-11 | S Sale | Large shareholder |
50,000
-1.1%
2.16USD 108,170 |
50,000 -1.1% | 2.16 | USD 108,170 | |
| 2021-06-14 | 2021-06-10 | S Sale | Large shareholder |
150,000
-3.1%
2.23USD 334,200 |
150,000 -3.1% | 2.23 | USD 334,200 | |
| 2020-12-28 | 2020-12-22 | S Sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
18,830
-2.6%
3.17USD 59,691 |
18,830 -2.6% | 3.17 | USD 59,691 | |
| 2020-12-28 | 2020-12-22 | S Sale | Large shareholder |
56,375
-2.6%
3.17USD 178,709 |
56,375 -2.6% | 3.17 | USD 178,709 | |
| 2020-12-22 | 2020-12-18 | S Sale | Large shareholder |
18,587
-0.9%
3.03USD 56,326 |
18,587 -0.9% | 3.03 | USD 56,326 | |
| 2020-12-22 | 2020-12-18 | S Sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
6,208
-0.9%
3.03USD 18,813 |
6,208 -0.9% | 3.03 | USD 18,813 | |
| 2020-04-20 | 2020-04-17 | PS Planned sale |
President and CEO Executive Director |
80,000
-33.2%
8.22USD 657,600 |
80,000 -33.2% | 8.22 | USD 657,600 | |
| 2019-05-21 | 2019-05-17 | B Purchase | Non-Executive Director |
40,000
+3.8%
9.00USD 360,000 |
40,000 +3.8% | 9.00 | USD 360,000 | |
| 2019-05-15 | 2019-05-13 | PS Planned sale |
President and CEO Executive Director |
21,306
-9.7%
8.89USD 189,381 |
21,306 -9.7% | 8.89 | USD 189,381 | |
| 2019-05-15 | 2019-05-13 | PS Planned sale |
President and CEO Executive Director |
123,500
-36.0%
8.89USD 1,097,915 |
123,500 -36.0% | 8.89 | USD 1,097,915 | |
| 2018-05-24 | 2018-05-24 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
25,000
-1.2%
5.51USD 137,750 |
25,000 -1.2% | 5.51 | USD 137,750 | |
| 2018-05-24 | 2018-05-24 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
50,000
-2.4%
5.65USD 282,500 |
50,000 -2.4% | 5.65 | USD 282,500 | |
| 2018-05-24 | 2018-05-24 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
45,700
-2.1%
6.00USD 274,200 |
45,700 -2.1% | 6.00 | USD 274,200 | |
| 2018-05-24 | 2018-05-24 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
38,000
-1.7%
5.99USD 227,620 |
38,000 -1.7% | 5.99 | USD 227,620 | |
| 2018-05-24 | 2018-05-24 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
29,300
-1.3%
5.84USD 171,112 |
29,300 -1.3% | 5.84 | USD 171,112 | |
| 2018-03-15 | 2018-03-13 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
200,000
-8.2%
10.07USD 2,014,000 |
200,000 -8.2% | 10.07 | USD 2,014,000 | |
| 2018-03-13 | 2018-03-09 | S Sale |
Berelowitz Michael |
7,500
-100.0%
10.45USD 78,347 |
7,500 -100.0% | 10.45 | USD 78,347 | |
| 2018-01-08 | 2018-01-04 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
1,579
-0.2%
8.84USD 13,956 |
1,579 -0.2% | 8.84 | USD 13,956 | |
| 2018-01-08 | 2018-01-04 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
4,732
-0.2%
8.84USD 41,822 |
4,732 -0.2% | 8.84 | USD 41,822 | |
| 2018-01-04 | 2018-01-03 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
19,863
-0.9%
8.73USD 173,464 |
19,863 -0.9% | 8.73 | USD 173,464 | |
| 2018-01-04 | 2018-01-03 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
6,635
-0.9%
8.73USD 57,943 |
6,635 -0.9% | 8.73 | USD 57,943 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
18,947
-0.9%
9.04USD 171,224 |
18,947 -0.9% | 9.04 | USD 171,224 | |
| 2018-01-04 | 2018-01-02 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
6,329
-0.9%
9.04USD 57,195 |
6,329 -0.9% | 9.04 | USD 57,195 | |
| 2018-01-02 | 2017-12-29 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
12,305
-0.6%
9.19USD 113,142 |
12,305 -0.6% | 9.19 | USD 113,142 | |
| 2018-01-02 | 2017-12-29 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
4,110
-0.6%
9.19USD 37,791 |
4,110 -0.6% | 9.19 | USD 37,791 | |
| 2018-01-02 | 2017-12-28 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
5,926
-0.3%
9.44USD 55,938 |
5,926 -0.3% | 9.44 | USD 55,938 | |
| 2018-01-02 | 2017-12-28 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
1,980
-0.3%
9.44USD 18,690 |
1,980 -0.3% | 9.44 | USD 18,690 | |
| 2017-12-28 | 2017-12-27 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
8,391
-0.4%
9.54USD 80,040 |
8,391 -0.4% | 9.54 | USD 80,040 | |
| 2017-12-28 | 2017-12-27 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
2,803
-0.4%
9.54USD 26,737 |
2,803 -0.4% | 9.54 | USD 26,737 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
SCP Vitalife Partners II LP Large shareholder |
4,798
-0.2%
9.59USD 46,016 |
4,798 -0.2% | 9.59 | USD 46,016 | |
| 2017-12-28 | 2017-12-26 | PS Planned sale |
SCP Vitalife Partners (Israel) II, L.P. Large shareholder |
1,602
-0.2%
9.59USD 15,364 |
1,602 -0.2% | 9.59 | USD 15,364 | |
| 2017-12-22 | 2017-12-21 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
40,000
-1.6%
9.80USD 392,000 |
40,000 -1.6% | 9.80 | USD 392,000 | |
| 2017-12-22 | 2017-12-21 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
11,000
-0.4%
9.84USD 108,240 |
11,000 -0.4% | 9.84 | USD 108,240 | |
| 2017-12-22 | 2017-12-20 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
25,000
-1.0%
10.00USD 250,000 |
25,000 -1.0% | 10.00 | USD 250,000 | |
| 2017-12-14 | 2017-12-13 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
8,237
-0.3%
9.80USD 80,723 |
8,237 -0.3% | 9.80 | USD 80,723 | |
| 2017-12-14 | 2017-12-13 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
9,900
-0.4%
9.84USD 97,416 |
9,900 -0.4% | 9.84 | USD 97,416 | |
| 2017-12-14 | 2017-12-12 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
50,000
-1.9%
9.80USD 490,000 |
50,000 -1.9% | 9.80 | USD 490,000 | |
| 2017-12-14 | 2017-12-12 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
100
-0.0%
9.89USD 989 |
100 -0.0% | 9.89 | USD 989 | |
| 2017-12-14 | 2017-12-12 | S Sale |
Broadfin Healthcare Master Fund Ltd Large shareholder |
25,000
-1.0%
10.00USD 250,000 |
25,000 -1.0% | 10.00 | USD 250,000 |